Welcome to our dedicated page for Kraig Biocraft Laboratories In news (Ticker: KBLB), a resource for investors and traders seeking the latest updates and insights on Kraig Biocraft Laboratories In stock.
Kraig Biocraft Laboratories reports recurring developments in recombinant spider silk technology, including production scale-up, new rearing capacity, cocoon output, and downstream reeling into usable silk fiber. The company’s technology is built around scientifically engineered silkworms that incorporate key spider silk proteins, with updates often tied to commercialization of materials for technical textiles, luxury wear, performance apparel, and other high-performance applications.
KBLB news also covers R&D execution, strain development, yield optimization, fiber performance, South East Asia production activity, and coordination with Prodigy Silk and related production networks.
Kraig Biocraft Laboratories (OTCQB: KBLB) announced that CEO and founder Kim Thompson authored a thought leadership editorial in Biocompare titled “Beyond Therapeutics: The Next Chapter of Synthetic Biology Is Manufacturing.” According to Kraig Biocraft Laboratories, the article introduces an “authored biology” framework, emphasizing enhancing proven natural systems, such as engineered silkworms, to produce recombinant spider silk at commercial scale.
The piece contrasts lab protein production with full-scale manufacturing and argues that synthetic biology’s next phase will be defined by consistent, economical, large-scale production. The company notes this perspective reflects its multi‑year effort to scale spider silk and supports its positioning in biology-enabled manufacturing and biomaterials, recently highlighted in a March 2026 National Geographic cover feature.
Kraig Biocraft Laboratories (OTCQB: KBLB) announced that its recombinant spider silk technology is the focus of a new Veritasium YouTube episode released around August 3, 2026. The segment takes viewers inside Kraig Labs’ labs and production facilities, showing how genetically engineered silkworms produce commercial spider silk fibers.
Veritasium hosts spent a full day with Kraig Labs’ scientists and engineers, then conducted a Spider-Man-inspired strength demonstration at a climbing gym, suspending people from Kraig’s spider silk. According to the company, this is among its broadest public introductions yet and complements earlier visibility, including a March 2026 National Geographic cover feature on its spider silk production work.
Kraig Biocraft Laboratories (OTCQB: KBLB) announced that CEO and founder Kim Thompson is featured in an in-depth interview in Just Style, a global apparel and textile trade publication. The article highlights Kraig Labs’ commercial-scale ramp-up in recombinant spider silk, tracing output from grams to kilograms, then hundreds of kilograms, and most recently to 2.5 metric tons of cocoon produced early this summer.
Thompson outlined a target of 10 metric tonnes of recombinant spider silk cocoon per month in 2026, potentially within 60 days, and emphasized the plug-and-play nature of the company’s transgenic silkworms within existing silk infrastructure, which already produces over 150,000 metric tons annually. The piece also presents recombinant spider silk as a premium, rare material suited to high fashion and situates Kraig Labs’ biology-enabled production model within a broader shift toward farm-grown, lab-designed textiles, alongside recent visibility such as a March 2026 National Geographic cover feature.
Summary not available.
Kraig Biocraft Laboratories (OTCQB: KBLB) announced a featured Pulse 2.0 interview with CEO Kim Thompson covering recombinant spider silk technology, commercial-scale production and long-term strategy.
Thompson describes leveraging existing global silk infrastructure, advances in genetically engineered silkworms, expansion in Southeast Asia, and target monthly metric-ton-level production for apparel, luxury fashion, technical and defense textiles.
Kraig Biocraft Laboratories (OTCQB:KBLB) reported a new all-time production record, harvesting nearly 2.5 metric tons of recombinant spider silk cocoons in a single May 15–June 4, 2026 cycle.
This milestone advances its 2026 expansion strategy, supported by added facilities, processing underway, and repeated record-setting production cycles.
Kraig Biocraft Laboratories (OTCQB: KBLB) reported early results from its current recombinant spider silk production cycle, with yields about 20% above internal targets, driving higher finished silk output.
If trends continue, this will be the company’s largest spider silk batch to date, with another, larger expansion cycle planned for June/July 2026. Kraig Labs’ biomaterials leadership was recently featured on the March 2026 National Geographic cover.
Kraig Biocraft Laboratories (OTCQB: KBLB) detailed its new immortalized silk gland cell platform, designed to use silkworm posterior silk gland cells for continuous recombinant protein production via natural exocytosis.
The approach aims to simplify purification, enable extended production cycles, and support scalable biomaterial manufacturing. Kraig Labs’ spider silk leadership was recently featured on the March 2026 cover of National Geographic.
Kraig Biocraft Laboratories (OTCQB: KBLB) announced the creation of an immortalized silkworm silk gland cell line, which shows strong proliferation, stable passaging, and robust long-term viability in vitro. Early tests indicate high recombinant protein expression and adaptability to suspension culture, potentially enabling scalable bioprocessing for therapeutics, vaccines, and advanced biomaterials.
Kraig Biocraft Laboratories (OTCQB: KBLB) commissioned a new recombinant spider silk production rearing center, now operating as part of its April/May 2026 production cycle. The facility was deployed in under 30 days within an aggressive scale-up program.
Kraig Biocraft uses standardized facility designs and a multi-center strategy to expand capacity, improve efficiency, and add operational resiliency as it advances toward commercial-scale spider silk production. The company plans continued 2026 capacity additions and was featured on the March 2026 cover of National Geographic.